A phase 2a and 2b randomized, double-blind, placebo-controlled study to assess the efficacy and safety of pacritinib in patients with VEXAS syndrome (PAXIS)

Principal Investigator

Dr Onima Chowdhury

Contact us

Email: Latephasehaematology@ouh.nhs.uk

IRAS number

1010876